iifl-logo

Orchid Pharma Ltd EGM

739.55
(3.53%)
Jul 1, 2025|12:00:00 AM

Orchid Pharma CORPORATE ACTIONS

02/07/2024calendar-icon
02/07/2025calendar-icon
PurposeAnnouncement DateMeeting Date
EGM29 May 202526 Jun 2025
COM 26/06/2025 Summary Proceedings of Honble NCLT convened meeting of Equity Shareholders of Orchid Pharma Limited to consider and approve the Scheme of Merger of Dhanuka Laboratories Limited with the Company and their respective shareholders and creditors (As Per BSE Announcement dated on 26.06.2025)

Orchid Pharma: Related News

Orchid Pharma Clears USFDA Inspection, Secures EU GMP Renewal
20 Feb 2025|03:36 PM

The inspection raised, seven minor observations none related to data integrity, and therefore, the facility remains compliant under stringent regulatory standards.

Read More
Read More

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.